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1  | INTRODUC TION
Missing data are a common problem in clinical trials, especially 
with long follow-up. Patients may leave the study for several rea-
sons related or not related to the therapeutic interventions and/or 
outcomes (Little et al., 2012), but the consequences for this loss to 
follow-up (LTFU) might be important.
Missing data can introduce attrition bias (Lewin, Brondeel, 
Benmarhnia, Thomas, & Chaix, 2018; Little et al., 2012) and may have 
an impact on the direction and size of the effect (Raboud, Montaner, 
Thorne, Singer, & Schechter, 1996). It is important to clarify that it is 
not necessarily the size of the losses that introduces bias but more 
importantly the missingness mechanism (Little et al., 2012). Losses 
related to the intervention and/or outcome may introduce post-ran-
domization bias as treatment arms may not be similar anymore as 
they were right after randomization potentially leading to an “un-
fair” comparison. Therefore, it is important during the analysis to 
consider losses and possible reasons for losses to follow-up as com-
plete case analysis results may differ substantially from the results 
using an intention-to-treat approach. An intention-to-treat analysis 
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Abstract
Aim: To assess the reporting and handling of incomplete outcome data in randomized 
clinical trials (RCTs) published in implant dentistry.
Materials and methods: We included RCTs on interventions related to the treatment 
with dental implants and presented any form of missing data. PubMed, SCOPUS and 
Cochrane databases were searched for studies published between May 2015 and 
May 2018. Reporting and handling of missing data at the study level were evaluated 
using a series of relevant questions. Descriptive data were reported, and univariable 
analyses were performed to evaluate the association of study variables with quality 
of reporting and data handling.
Results: One-hundred and thirty-seven RCT reports were included from the 7,116 
initially retrieved publications. The reporting of incomplete outcome data varied 
greatly among the trials and for the different questions. The range of adequately 
reported questions was between 3.64% (question: comparison of baseline character-
istics of all randomised participants) and 100% (question: explicit reporting of missing 
data). The complete case analysis was the most used (45.3%) approach for incom-
plete outcome data handling.
Conclusions: Randomized studies in implant dentistry have room for improvement in 
both the reporting and the handling of incomplete outcome data.
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requires a complete dataset which in the presence of missing data is 
not possible unless a complete dataset is reconstructed. Various im-
putations methods exist with multiple imputations being among the 
more appropriate methods as they generate multiple complete data-
sets based on a predictive distribution for the outcome variable and 
they account for the uncertainty due to the missing data (Fleming, 
2011; Little et al., 2012, 2010; Little & Rubin, 2002; May et al., 1981; 
Robins, Rotnitzky, & Zhao, 1995; Seaman & White, 2013). Potential 
bias elimination via multiple imputation requires that the missingness 
in the outcome does not depend on its true value other than through 
measured variables included in the imputation model and that the 
model is correctly specified (Rubin, 1987; Sterne et al., 2009).
Therefore, when interpreting trial results with losses to follow it 
is important to understand the missingness mechanism. This miss-
ingness mechanism may belong into one of the following categories 
(Little & Rubin, 1987): missing completely at random (MCAR), miss-
ing at random (MAR) and missing not at random (MNAR). To be able 
to better recognize the missingness mechanism, it is necessary that 
all relevant information is included in the publication accurately and 
transparently (Hollis & Campbell, 1999).
To show potential differences between only complete cases (PP) 
and ITT analyses, we have simulated data for a relevant clinical com-
parison taken from a recently published study (Donati, Ekestubbe, 
Lindhe, & Wennström, 2018). In this trial, the marginal bone loss was 
compared between non-modified turned and modified and roughened 
dental implant surfaces. We used the reported per treatment arm 
means (taken as positive value) and standard deviations for marginal 
bone loss for the 5-year time point in order to produce the simulated 
full dataset (ITT dataset). For simplification purposes, a normal dis-
tribution of the data was assumed and for the analysis purposes one 
implant per patient. We simulated 5 complete case only datasets (PP 
dataset) with 10%, 20%, 30%, 40% and 50% losses to follow-up. In 
the PP datasets for all % missing scenarios the largest values from one 
treatment arm were removed and the lowest values from the other 
treatment arm. This MNAR approach created a best-case scenario (all 
losses had a positive outcome) for one treatment arm and a worst-case 
scenario (all losses had a negative outcome) for the other treatment 
arm. We fitted univariable linear regression models for the full and the 
complete case only datasets simulating the intention-to-treat (ITT) and 
the per-protocol (PP) analyses, respectively. Table 1 and Figure 1 show 
clearly how the estimates for ITT and PP analyses per simulated % 
data loss diverge. We can see that as the % of losses increase the treat-
ment effects for PP become larger on an absolute basis and that from 
20% losses and on the PP results are significant as the 95% confidence 
intervals do not include zero. This is expected given the MNAR nature 
of the simulated losses as explained earlier. Obviously, the adopted 
scenario is an extreme scenario and it is applied to show the potential 
problems with ignoring missing data; however, this is only one scenario 
among several. It is of interest to note that in the Donati et al paper 
used for this simulation from the 148 originally placed implants, 137 
(92.6%), 112 (75.7%), 62 (40.5%) and 64 (43.2%) were assessed at the 
5, 8, 12 and 20-year intervals, respectively. This simulation indicates 
the need to decrease losses to follow-up during the trial conduct as 
much as possible and also the importance of fully reporting losses to 
follow-up and handling of missing data.
The objectives of the present study were twofold: (a) to assess 
the reporting and handling of missing outcome data in RCTs pub-
lished in implant dentistry and (b) to examine trial characteristics 
that may be associated with LTFU.
2  | MATERIAL S AND METHODS
2.1 | Eligibility criteria
We included reports of RCTs published in implant dentistry adhering 
to the following criteria:
• Any intervention related to dental implants, any clinical outcome, 
a sample size of at least 10 patients, and in the English language. 
When articles reported different follow-ups of the same study, we 
included the article reporting the longest follow-up.
We excluded the following documents:
• Reports of RCTs without interventional purposes (e.g. no thera-
py-related outcome).
• RCTs reporting only on non-clinical endpoints (e.g. microbiologi-
cal findings) or not having any missing data in the form of patient 
dropout.
• In vitro studies, animal studies and non-RCTs studies.
• Studies with only missing data on dental implants, but without 
patient dropout.
Clinical Relevance
Scientific rationale for the study: There is so far no infor-
mation on how authors of randomized studies in implant 
dentistry report and handle incomplete outcome. Bias in 
estimates may occur when different types of analyses are 
performed in the presence of missing data.
Principal findings: The findings demonstrate that the report 
of incomplete outcome data can be improved. Some infor-
mation was poorly addressed in the included trials, such as 
the baseline characteristics of participants lost to follow-
up (LTFU) compared to those who remained in the study, 
or the implications of LTFU in the context of trials findings. 
Furthermore, complete case analysis was the most com-
mon approach used in this sample of RCTs.
Practical implications: Transparent and accurate reporting 
of missing data may contribute to a more accurate and less 
biased assessment of trial results. The present findings 
may increase awareness in the problem of missing data and 
guide the planning and conduct of more robust trials.
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2.2 | Literature search and selection of RCT reports
Two authors (RL and CMF) searched for RCTs published from May 
2015 to May 2018 in MEDLINE (via PubMed), SCOPUS and in the 
Cochrane Central Register of Controlled Trials (CENTRAL) da-
tabases. All terms used in the searches were combined with the 
Boolean logic operators “OR” and “AND.” Full search strategies in the 
electronic databases are reported in the supplementary file (Table 
S1). Additionally, the authors manually searched reference lists of 
selected publications to identify relevant articles. The selection pro-
cess followed the eligibility criteria and started from the title and the 
abstract. Excluded papers with reasons for exclusion were recorded. 
Full-text publications were retrieved for the studies that passed the 
title and abstract screening stage. After full-text assessment, papers 
not meeting eligibility criteria were excluded and reasons for exclu-
sion noted.
All searches and the selection of RCTs fulfilling the eligibility 
criteria were conducted independently and in duplicate by two au-
thors (RL and CMF). Disagreements regarding study selection were 
resolved by consensus among all authors.
2.3 | Data extraction
Information from the selected RCTs was retrieved and recorded on 
standardised forms. As suggested by AMSTAR-2 (Shea et al., 2017), the 
two reviewers initially extracted data from a sample of eligible studies 
and once they achieved good agreement (at least 80%), the remaining 
Percentage of missing values 









10% 0.09 −0.08, 0.26 −0.12 −0.27, 0.04
20% 0.09 −0.08, 0.26 −0.29 −0.44, −0.14
30% 0.09 −0.08, 0.26 −0.45 −0.59, −0.30
40% 0.09 −0.08, 0.26 −0.58 −0.72, −0.43
50% 0.09 −0.08, 0.26 −0.73 −0.88, −0.58
Abbreviation: ITT, intention-to-treat; PP, per protocol.
TA B L E  1   Simulated estimates for 
marginal bone loss (in mm) between 
treatment groups using complete case 
only and ITT analyses with different 
percentages of losses
F I G U R E  1   Treatment estimates with 95% confidence intervals for intention-to-treat (ITT-upper horizontal line) and per-protocol (PP-
lower decreasing line) analyses across 10%-50% simulated losses to follow-up
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data extraction was completed by one reviewer. The data extraction 
forms contained the following information: RCT design (parallel, split-
mouth, non-inferiority, factorial, adaptive and other), RCT analysis (ITT 
and PP),number of arms, sample size, title of the study, year of publi-
cation, number of citations in Google Scholar, country of affiliation of 
the first author, number of participants/implants, type of intervention 
(non-surgical, surgical, prosthetic and pharmacologic), outcome meas-
ure (continuous or categorical), impact factor (IF) and type of sponsor-
ship. In order to maximize the efficiency of the analysis, we used the 
number of citations reported one year after the date of the literature 
search. The second reviewer (CMF) checked items at random for ac-
curacy, and when disagreements were found, they were resolved by 
discussion and consensus.
2.4 | Missing data reporting and handling
Several questions related to missing data were addressed. In a first 
stage, we assessed how authors reported follow-up information. The 
checklists for reporting (Akl et al., 2009) of missing outcome data han-
dling (Wood, White, & Thompson, 2004) are shown in Table 2. A two-
level scoring was used depending on the reporting of an item or not. 
Items adequately reported received a YES score. If the information was 
not reported, a score of NO was noted. For missing data handling, the 
statistical approach used by the authors of the RCTs to handle missing 
data was recorded (Table 2). Disagreements were resolved by discus-
sion until consensus was achieved. An experienced statistician (NP) 
checked the assessment of missing data for accuracy.
Before the assessments, we independently underwent three 
rounds of calibration by evaluating 6 RCTs not included in the pres-
ent review. We selected these RCTs by using an online randomisa-
tion software (http://www.rando mizer.org) from the MEDLINE (via 
PubMed) database.
2.5 | Statistical analysis
We summarised the results of missing data reporting and handling 
in tables. We calculated frequencies per RCT reporting character-
istic in different-year time periods to assess the changes in trends 
based on the assessment criteria and reported medians interquar-
tile ranges (IQR) for citation counts and impact factor. We used 
Fisher's exact test to assess possible associations between RCT 
characteristics and missing data handling (Yes: study performed 
missing data handling; No: study did not report any form of missing 
data handling). In order to examine potential associations between 
the ordinal score on the quality of reporting of missing data (out-
come) and the predictors type of analysis (ITT, PP and both), type 
of treatment, COI, sponsorship, IF or geographic location median 
regression was implemented. A Poisson model was fitted to assess 
any associations between the number of citations (outcome) and 
the quality of reporting of missing data score (predictor). The coef-
ficients are presented as risk ratios (RR) with their respective confi-
dence intervals (CI). Statistical significance was set at alpha = 0.05, 
and all analyses were conducted using Stata 15.1 (Stata Corp).
3  | RESULTS
3.1 | Studies included
The initial search retrieved 2,710 documents in PubMed, 2,123 in 
Cochrane and 2,283 in SCOPUS databases. After removing duplicates 
among different databases and journals (n = 6,113), 1,003 documents 
had their titles/abstracts assessed. After assessment of titles and ab-
stracts, 589 documents were excluded. After full-text analysis, 137 ar-
ticles were included in this study. The search and selection processes 
are described in detail in Figure 2. A full list of publication retrieved 
with reasons for exclusions are reported in the supplementary file.
3.2 | Characteristics of the RCTs
The most prevalent RCT design was the parallel design (N = 119, 86.9%) 
with most studies (N = 50, 36.5%) being published in 2017. The total 
TA B L E  2   Items related to the missing data reporting and 
handling
Items related to the missing data reporting (Akl et al. 2009)
1. The proportion of RCTs that explicitly reported whether loss to 
follow-up (LTFU) occurred or not
2. The proportion of RCTs that reported a CONSORT flow dia-
gram with LTFU provided
3. The proportion of RCTs that reported loss to follow-up 
separately for the 2 comparison groups (3.a patients; 3.b dental 
implants)
4. The proportion of RCTs that reported loss to follow-up at each 
planned outcome assessment;
5. The proportion of RCTs that compared the baseline character-
istics of participants LTFU to those not LTFU and the proportion 
that compared the baseline characteristics of those LTFU in 
intervention and control groups
6. The proportion of trials that discussed the implications of loss 
to follow-up in the context of their findings.
Items related to missing data handling (Wood et al., 2004)
1. Complete case: excludes subjects with missing outcome
2. Last observation carried forward (LOCF): imputes missing 
values with the individual's last observation
3. Worst-case imputation: imputes all missing values with the 
worst-case value
4. Regression imputation: missing outcomes are predicted from 
the individual's observed data, using a model based on observed 
individuals
5. Repeated measures: all observed outcomes are modelled, al-
lowing for correlation between the individual's observations
6. Sensitivity analysis: analysis which directly assess the assump-
tions made in primary analysis
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number of patients treated in the included RCTs was 8,049 with most 
(N = 122, 89.1%) trials having two treatment arms. Most (N = 117, 
85.4%) RCTs did not clearly report the type of analysis (ITT vs. per 
protocol) used. Italy was the most prevalent country according to first 
author affiliation (N = 33, 24%). Ninety-seven (70.8%) of the articles 
reported continuous variables as primary outcomes. Most (N = 97, 
70.8%) of the interventions reported in the articles were a combination 
of surgical and prosthetic treatments and were published in implant 
dentistry (N = 82, 59.9%) journals. The median IF of the journals in this 
sample was 3.097 (IQR = 1.699), and the median number of citations of 
the included articles was 9 (IQR = 14.5). The detailed information about 
the RCTs characteristics are reported in Table 3.
3.3 | Missing data reporting
A flow diagram describing LTFU was reported in 65 (47.5%) of the 
RCTs. The LTFU at patient level was separately reported for test and 
control groups in 135 (98.5%) of the RCTs. The LTFU at implant level 
was separately reported for test and control groups in 92 (67.2%) of 
the RCTs. The comparison of baseline characteristics of participants 
LTFU to those not LTFU was reported in 5 (3.6%) of the trials. Twenty 
(14.6%) of the RCTs discussed the implications of LTFU. Seventy-six 
(55.5%) RCTs reported LTFU in their abstracts. One-hundred sev-
enteen (85.4%) of the articles reported the reasons for dropout. 
The complete information on missing data reporting is described in 
Table 4.
3.4 | Missing data handling
In the present sample of 137 RCTs, 62 (45.3%) of the studies re-
ported a complete case analysis. One (0.7%) trial applied the LOCF 
approach, two (1.5%) trials used the worst-case scenario imputation 
and one (0.7%) trial applied the baseline-observation-carried-for-
ward (BOCF) approach. For 71 (51.8%) of the studies, there was no 
description of the approach used to address missing data handling. 
Fisher's exact test indicated no association between missing data 
handling and trial characteristics (Table 5).
3.5 | Regression analysis
Median regression indicated an association between the score on the 
quality of reporting of missing data and the type of analysis (p = .04, 
Wald test), type of treatment (p < .001, Wald test). No associations 
F I G U R E  2   Flow of the searching and 
selection process
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were found between the score on the quality of reporting of missing 
data and COI, sponsorship, impact factor or geographic location (Table 
S2, supplementary file). Studies better reporting LTFU were associated 
with a greater number of citations (RR: 1.056, CI: 1.017, 1.102, p = .006).
4  | DISCUSSION
4.1 | Key findings
Our study attempted to examine how RCTs published in implant 
dentistry report and handle missing data. The present findings 
TA B L E  3   Characteristics of 137 included articles


























New Zealand 2 (1.5)
Norway 1 (0.7)
Poland 1 (0.7)


















Article characteristics Frequency (%)
Non-inferiority 3 (2.2)
Not stated 85 (62)
RCT analysis
Intention-to-treat 8 (5.8)
Per protocol 8 (5.8)
Intention-to-treat and per protocol 4 (2.9)
Unclear 117 (85.4)





Periodontology journal 22 (16.1)
General dentistry journal 29 (21.1)
Medical journal 1 (0.7)
Dental implantology journal 82 (59.9)
Prosthodontic journal 1 (0.7)
Periodontology and implantology journal 2 (1.5)







Surgical & prosthetic 97 (70.8)
Non-surgical & pharmacological 5 (3.6)
Surgical & pharmacological 6 (4.4)
Surgical & pharmacological & prosthetic 1 (0.7)
Impact factor
Median (IQR) 3.097 (1.699)
Google citations
Median (IQR) 9 (14.5)
Abbreviation: IQR, interquartile range.
TA B L E  3   (Continued)
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suggest that there is room for improvement in the quality of report-
ing of missing data in these trials. Furthermore, the strategies for 
handling missing data were not reported in half of these trials, with 
the “complete cases analysis” being the most frequent approach for 
missing data handling. Our findings provide comprehensive informa-
tion on the current status on handling and reporting of missing data 
and may help to guide more robust future trials.
4.2 | Interpretation and implications
The lack of information on handling of LTFU might have important im-
plications on the results of RCTs, mainly on those which have greater 
patient losses or where data are not missing at random. Some studies 
lost almost 50% of the originally randomized patients. Therefore, in-
complete outcome data in these studies might be an important source 
of attrition bias that can possibly interfere with treatment estimates 
(Yao et al., 2017) and their precision given the lower than planned 
sample size (Spineli, Fleming, & Pandis, 2015). Again, it is important to 
emphasize that incomplete data may not lead to baseline imbalances 
in the evaluated primary outcome as this depends on the missingness 
mechanism (Hewitt, Kumaravel, Dumville, & Torgerson, 2010).
As pointed out earlier, assumptions on the relationship between 
incomplete data due to dropouts and influence on the treatment 
effects based on the quantity and the pattern of dropouts may be 
misleading (Bell, Kenward, Fairclough, & Horton, 2013). The keys 
for evaluating attrition bias are the reasons for dropouts and the 
approach used to deal with missing data (Bell et al., 2013; Rubin, 
1976; Spineli et al., 2015). When data are MCAR (Little et al., 2012; 
Spineli et al., 2015): missing data are completely unrelated to the 
study variables. In this scenario patients leaving the study consti-
tute a random sample of the study participants with similar event 
probability of having the outcome with those remaining in the study 
(Bell et al., 2013). MAR dropouts can be explained by the observed 
characteristic such as baseline characteristics. The response of the 
dropouts can be inferred from the response of those who remain 
in the study (Carpenter & Kenward, 2013). Methods such as direct 
likelihood would be valid but not generalized estimating equations 
(GEE) unless appropriate adjustments are implemented (Fitzmaurice, 
Molenberghs, & Lipsitz, 1995; Molenberghs & Kenward, 2007).
MNAR dropouts are directly associated with the outcome or 
outcome related side-effects. Missing data depends on the unob-
served data, even after taking into account all the information in 
the observed data as in MAR. Under MNAR, inference is harder 
than MCAR or MAR because both the response of interest and 
the missingness mechanism must be considered (Carpenter & 
Kenward, 2013).
In our sample, the most common approach was the “complete 
case analysis” (N = 62, 45.3%), and this is in agreement with other 
studies (Fiero, Huang, Oren, & Bell, 2016; Powney, Williamson, 
Kirkham, & Kolamunnage-Dona, 2014). This method can be mislead-
ing in many occasions, because it considers that all data were MCAR, 
most likely an unrealistic assumption. One potential strategy would 
be to try to impute missing data and perform sensitivity analyses 
under various and plausible scenarios. If the sensitivity analyses 
do not change the study's conclusions, it is likely that missing data 
are not a threat to the study's validity (Bankhead, Aronson, Nunan, 
2017). The number of trials using sensitivity analysis to evaluate 
the robustness of results when missing data are present seems to 
be low (Fiero et al., 2016). In half of the included trials in our study 
the method used to handle missing information was unclear. This is 
higher than a previously published review of RCTs published in five 
major medical journals which concluded that 19% of the trials did not 
report the method for handle LTFU (Akl et al., 2012).
In implant dentistry two levels of missing data may occur: at pa-
tient and at dental implant level. We may consider two different out-
comes for implant loss: the first outcome is that resulting from the 
intervention applied or any disease involved (e.g. peri-implantitis) 
with the therapy. Therefore, this type of implant loss is not consid-
ered missing data, but it is an outcome. However, when the implants 
are lost in a very early stage (before occlusal load was applied), then 
we may consider missing values when this loss is not accounted for 
in the statistical analysis.
Interestingly, the intervention type was associated with more 
losses to follow-up. Trials including surgical and prosthetic phases 
(i.e. placement of dental implants plus dental prostheses) had greater 
losses compared to surgery alone. These results might be explained 
by the potentially longer follow-up periods in these studies. Similarly, 
inclusion of both ITT and PP analysis in the RCTs was associated with 
greater losses to follow-up than in trials with other types of analysis. 
However, such a finding is difficult to interpret but could be related 
with just better reporting and authors being more aware of the miss-
ing data consequences.
Many studies reported baseline characteristics of the patients 
included, but only a few reported the baseline characteristics of pa-
tients who dropped out of the study. Reporting of baseline charac-
teristics should be detailed enough to allow the reader to understand 
whether any difference on patient's characteristics might have an 
influence on the reason for the dropout and may be associated with 
the outcome. Item 4 (“The proportion of RCTs that compared the 
baseline characteristics of participants LTFU to those not LTFU and 
the proportion that compared the baseline characteristics of those 
LTFU in intervention and control groups”) was considered inade-
quately reported in 50% of the trials.
4.3 | Strength and limitations
This study included a sample of RCTs (N = 137) published mostly 
(N = 132) in IF journals. We feel that this sample is representative of 
the best evidence available in the field of implant dentistry. Due to 
the lack of good reporting, regarding the approaches used to handle 
missing data, it was not possible to adequately examine statistically 
potential associations between articles' characteristics and missing 
data handling. In many occasions, there was absolutely no report 
on the missing data handling or it was necessary to interpret which 
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approach was used (e.g. in the case of “complete case” analysis, when 
authors did not explicitly report the approach, but the text sug-
gested that the missing variables were removed from the analysis). 
The regression analysis indicated a positive association between 
better LTFU reporting and a higher number of citations. Although 
it is difficult to determine a clear reason for this association, these 
Question Yes (%) No/Unclear (%)
1. Did the randomized controlled trial (RCT) 
explicitly report whether lost to follow-up (LTFU) 
occurred or not?
137 (100) 0 (0)







3a. Did the RCT report loss to follow-up separately 
for the 2 comparison groups? (Patients)
135 (98.5) 2 (1.5)
3b. Did the RCT report loss to follow-up separately 
for the 2 comparison groups? (Implants only)
92 (67.2) 45 (32.8)
4. Did the RCT report loss to follow-up at each 
planned outcome assessment?
68 (49.6) 69 (50.4)
5. Did the RCT compare the baseline characteristics 
of participants LTFU to those not LTFU and the 
proportion that compared the baseline character-
istics of those LTFU to in intervention and control 
groups?
5 (3.6) 132 (96.4)
6. Did the RCT discuss the implications of the LTFU 
in the context of their findings?
20 (14.6) 117 (85.4)
7. Did the abstract report any information about 
missing data?
76* (55.5) 61 (44.5)
*Four abstracts only reported missing data on dental implants. 
TA B L E  4   Missing data reporting
Characteristic No (%) Yes (%) Total (%) Fisher Exact test
RCT analysis
Unclear 62 (53) 55 (47) 117 (85.4) 0.075
Intention-to-treat 3 (37.5) 5 (62.5) 8 (5.8)  
Per protocol 6 (75) 2 (25) 8 (5.8)  
Intention-to-treat 
and per protocol
0 (0) 4 (100) 4 (3)  
COI
No Report of COI 70 (52.2) 64 (47.8) 134 (97.8) 0.609
Report of COI 1 (23.3) 2 (66.7) 3 (2.2)  
Sponsorship
Unclear/no funding 21 (67.7) 10 (22.3) 31 (22.6) 0.136
Non-profit 16 (47.1) 18 (52.9) 34 (24.8)  
Industry 34 (47.2) 38 (52.8) 72 (52.6)  
Intervention
Non-surgical 7 (70) 3 (30) 10 (7.3) 0.405
Surgical 13 (48.5) 16 (61.5) 29 (21.2)  
Surgical & prosthetic 51 (52) 47 (48) 98 (71.5)  
Continent
Africa 2 (50) 2 (50) 4 (2.9)  
Americas 14 (77.8) 4 (22.8) 18 (13.1) 0.110
Asia 10 (44.5) 12 (54.5) 22 (16.1)  
Europe 45 (48.4) 48 (51.6) 93 (67.9)  
TA B L E  5   Distribution of trial 
characteristics in the presence or absence 
of statistical approach for missing data 
handling at the trial level
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findings may suggest that researchers may be more interested in 
trials with a more comprehensive reporting of all trial aspects in-
cluding missing data. Furthermore, the inclusion of only articles in 
English might have introduced some sort of language bias. Finally, 
it was challenging to determine the sample of studies. It would be 
challenging to include studies representative from all time periods. 
We would need to include a larger number of RCTs that would make 
the study not feasible. Therefore, we decided to focus on the most 
recent publications in a 3-year time frame. However, we understand 
that by selecting the most recent published RCTs our findings may 
be more optimistic due to the expected increased awareness over 
time of the importance of methodological principles in research. 
Finally, we included only clinical outcomes, because they might be 
considered the most important outcomes for decision-making and 
are more in line to patient-important outcomes and the COMET ini-
tiative (Wolters et al., 2016).
4.4 | Further research
The analysis of missing data reporting and handling should be fur-
ther performed in other dental fields to understand how authors 
of the other dental disciplines address this issue. It is also evident 
that there is a need to increase awareness among investigators in 
dentistry about the perils of ignoring or mishandling missing data. 
Furthermore, it would be also important to evaluate how the results 
of published trials in dentistry with incomplete data could change 
under different missingness assumptions. However, it would be 
necessary to have access to raw datasets in order for this to be ac-
complished. Authors of RCTs should also consider efficient strate-
gies for retaining study participants (Robinson, Dennison, Wayman, 
Pronovost, & Needham, 2007). This would potentially contribute to 
the reduction of missing data, a problem especially in studies with 
long observation periods.
5  | CONCLUSIONS
The present study found that the majority of RCTs in implant den-
tistry do not report any information on how authors handled miss-
ing data. The most used approach to deal with missing data was 
the “complete case analysis” which can be problematic in terms 
of bias and precision. Authors of RCTs in implant dentistry should 
focus on a more comprehensive report of reasons for dropouts 
in order to choose the best approach for dealing with missing in-
formation. Analysis of missing data involving imputations requires 
knowledge of relevant statistical methodology. We understand 
that our results have important research and clinical implications. 
Authors of future trials will likely be more aware on the adequate 
reporting and handling of missing data. Clinicians reviewing im-
plant dentistry publications will be better informed about the 
potential limitations due to missing data in the decision-making 
process.
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